Pharmaceutical Biotechnology MCQs for GPAT, NIPER & Pharmacist Exams

Introduction to Pharmaceutical Biotechnology: Concise Notes for Competitive Exams

Introduction

Pharmaceutical biotechnology is the application of biotechnology to the discovery, development, production, and characterization of medicines. It uses living organisms, cells, enzymes, and biological processes to develop therapeutic and diagnostic products.

Unlike many conventional drugs produced by chemical synthesis, biotechnology allows the production of complex biological products such as recombinant proteins, monoclonal antibodies, vaccines, therapeutic enzymes, cell therapies, and gene therapies.

For competitive examinations such as GPAT, NIPER, AIIMS Pharmacist, Railway Pharmacist, SSC, ESIC, and State Pharmacist exams, it is important to understand both the basic concepts and the differences between closely related terms.

1. Biotechnology in Pharmaceutical Sciences

Biotechnology uses living systems or biological processes to develop useful products. Pharmaceutical biotechnology applies these principles to modern drug discovery, development, manufacturing, and diagnostics.

Major biotechnology-derived products

• Recombinant proteins – insulin, growth hormone, erythropoietin, interferons

• Monoclonal antibodies – targeted therapies

• Vaccines – recombinant and subunit vaccines

• Therapeutic enzymes – enzyme replacement therapies

• Gene therapies

• Cell-based therapies

• Biosimilars – biological products highly similar to an approved reference product

Takeaway

Pharmaceutical Biotechnology = Biology + Technology → Modern Medicines

2. Protein Therapeutics

Protein therapeutics are medicines in which proteins or peptides produce the desired therapeutic effect.

Important examples

• Protein Therapeutic Major Application

• Insulin Diabetes mellitus

• Erythropoietin (EPO) Anemia

• Human growth hormone Growth hormone deficiency

• Interferons Viral infections and certain cancers

• Coagulation factors Hemophilia

• Monoclonal antibodies Cancer and autoimmune diseases

Advantages

• High specificity for biological targets

• Can replace missing or defective proteins

• Useful for treating complex diseases

• Can selectively act on specific biological pathways

Limitations

Protein therapeutics are generally sensitive to:

• Temperature

• pH changes

• Oxidation

• Light

• Agitation

• Proteolytic degradation

They may undergo:

• Denaturation – loss or alteration of normal protein structure

• Aggregation – association of protein molecules

• Degradation – chemical or enzymatic breakdown

Protein aggregation may reduce biological activity and can potentially increase immunogenicity.

Protein Structure: Quick Revision

• Primary structure → Amino acid sequence

• Secondary structure → α-helix and β-sheet

• Tertiary structure → Three-dimensional structure of a single polypeptide

• Quaternary structure → Association of multiple polypeptide chains

Takeaway

Protein therapeutics → Highly specific but structurally sensitive

3. Analytical Characterization of Proteins

Protein characterization is essential to establish the identity, purity, molecular size, structure, stability, and biological properties of therapeutic proteins.

Important analytical techniques

• Technique Main Purpose

• SDS-PAGE Separates proteins mainly according to molecular size under denaturing conditions

• Size-Exclusion Chromatography (SEC) Separates proteins according to size; useful for detecting aggregates

• Ion-Exchange Chromatography Separates proteins based on charge

• Isoelectric Focusing (IEF) Separates proteins according to isoelectric point (pI)

• Mass Spectrometry (MS) Determines molecular mass and helps characterize molecular modifications

• ELISA Detects or measures specific proteins or antigens using antibodies

• Western Blotting Detects a specific protein

• Circular Dichroism (CD) Provides information about protein secondary structure

Memory Trick

SDS-PAGE → Size
SEC → Size + Aggregation
IEF → pI
MS → Molecular Mass
ELISA → Specific Detection

Takeaway

In exam questions, remember that SDS-PAGE and SEC both involve size, but SDS-PAGE is an electrophoretic method performed under denaturing conditions, whereas SEC separates molecules according to their size or hydrodynamic volume and is particularly useful for studying aggregation.

4. Monoclonal Antibodies (mAbs)

A monoclonal antibody (mAb) is an antibody produced by a single B-cell clone and is highly specific for a particular epitope.

Hybridoma Technology

The classical method of monoclonal antibody production involves the fusion of:

Antibody-producing B lymphocyte + Immortal myeloma cell → Hybridoma

The resulting hybridoma:

• Produces a specific antibody

• Can multiply continuously

• Produces large quantities of identical antibodies

Important Antibody Regions

Fab Region

• Mainly responsible for antigen binding

• Contains the antigen-binding site

• Determines antigen specificity

Fc Region

• Responsible for important effector functions

• Interacts with Fc receptors

• Participates in immune mechanisms

Variable Region

• Determines antigen-binding specificity

• Contains the complementarity-determining regions (CDRs)

Constant Region

• Determines the characteristic antibody class

• Contributes to effector functions

Applications of Monoclonal Antibodies

• Cancer treatment

• Autoimmune diseases

• Inflammatory disorders

• Transplantation

• Diagnostic testing

• Targeted therapy

Takeaway

Fab = Finds and Binds antigen
Fc = Facilitates effector functions

Monoclonal = One clone → Highly uniform specificity

5. Antigens and Related Immunological Concepts

Antigen

An antigen is a substance that can be specifically recognized by components of the immune system, such as antibodies or immune receptors.

Important: An antigen is not necessarily capable of inducing an immune response.

Epitope

An epitope, also called an antigenic determinant, is the specific part of an antigen recognized by an antibody or immune receptor.

Immunogen

An immunogen is a substance capable of inducing an immune response.

Hapten

A hapten is a small molecule that can be recognized by the immune system but generally cannot induce an immune response by itself.

When attached to a suitable carrier protein, a hapten can become immunogenic.

Easy Memory Trick

Antigen → Recognized
Immunogen → Induces an immune response
Hapten → Needs a carrier to become immunogenic
Epitope → Specific part recognized

Takeaway

Antigen and immunogen are not always synonymous: an antigen can be recognized by the immune system, whereas an immunogen can induce an immune response.

6. Enzyme Immobilization

Enzyme immobilization is the process of fixing or confining an enzyme to a solid support or within a matrix while retaining its catalytic activity.

Major Methods

1. Adsorption

The enzyme is attached to the surface of a support through relatively weak forces.

Advantages:

• Simple

• Inexpensive

Limitation:

• Enzyme may leak from the support

2. Covalent Binding

The enzyme is chemically attached to the support.

Advantages:

• Strong attachment

• Reduced enzyme leakage

Limitation:

• Activity may decrease if important functional groups are affected

3. Entrapment

The enzyme is physically trapped within a gel or polymer matrix.

The enzyme is not necessarily chemically bound to the matrix.

4. Encapsulation

The enzyme is enclosed within a semipermeable membrane.

5. Cross-Linking

Enzyme molecules are chemically linked to one another using cross-linking agents.

Advantages of Immobilized Enzymes

• Enzyme can be recovered and reused

• Easier separation of enzyme from the product

• Improved operational stability

• Suitable for continuous processing

• May reduce production costs

Limitations

• Diffusion or mass-transfer problems

• Possible reduction in enzyme activity

• Higher initial immobilization cost

Takeaway

Immobilized enzyme = Reusable enzyme + Easy separation

Exam focus: Covalent attachment is strong and minimizes leakage, whereas adsorption is simpler but may allow enzyme desorption.

7. Cell Culture

Cell culture is the growth and maintenance of cells under controlled conditions outside the original organism.

Types of Cell Culture

Adherent Cells

• Require attachment to a solid surface for growth.

Suspension Cells

• Grow freely in liquid culture medium.

• Suitable for large-scale production in bioreactors.

CHO Cells

Chinese Hamster Ovary (CHO) cells are widely used for the production of therapeutic proteins and monoclonal antibodies.

Why are CHO cells important?

CHO cells can perform many important mammalian post-translational modifications, including appropriate protein folding and glycosylation.

This makes them particularly useful for producing complex therapeutic proteins that require mammalian-like processing.

Applications of Cell Culture

Cell culture is used for producing:

• Recombinant proteins

• Monoclonal antibodies

• Vaccines

• Viral vectors

• Cell-based therapies

Takeaway

CHO cells → Major mammalian production system for therapeutic proteins and monoclonal antibodies

8. Cell Immobilization

Cell immobilization is the process of restricting living cells within a defined region while allowing nutrients, substrates, oxygen, and products to move through the system.

Common Methods

• Entrapment

• Encapsulation

• Adsorption

• Covalent attachment

Advantages

• Cells can be retained and reused

• High cell concentration can be maintained

• Easier separation of cells from products

• Useful for continuous bioprocessing

Major Limitation

The most important limitation is often mass transfer limitation.

Poor diffusion of:

• Oxygen

• Nutrients

• Substrates

and accumulation of:

• Metabolic waste

may reduce cell growth and productivity.

Takeaway

Cell immobilization → Cells stay in place, while nutrients and products move

9. Pharmaceutical Applications of Biotechnology

Pharmaceutical biotechnology has applications throughout modern drug development.

1. Drug Discovery

• Identification of biological targets

• Recombinant DNA technology

• Molecular biology techniques

2. Therapeutic Proteins

Examples include:

• Insulin

• Growth hormone

• Erythropoietin

• Interferons

• Coagulation factors

3. Monoclonal Antibodies

Used in:

• Cancer therapy

• Autoimmune diseases

• Inflammatory diseases

• Targeted therapies

4. Vaccines

Biotechnology contributes to:

• Recombinant vaccines

• Subunit vaccines

• Other modern vaccine platforms

5. Enzyme Technology

Applications include:

• Therapeutic enzymes

• Enzyme replacement therapy

• Biocatalysis

• Pharmaceutical processing

6. Cell Culture

Used for:

• Recombinant protein production

• Monoclonal antibody production

• Vaccine production

• Viral vector production

7. Cell and Gene Therapy

Applications include:

• Treatment of inherited disorders

• Cancer therapy

• Regenerative medicine

8. Diagnostics

Biotechnology is used in:

• ELISA

• Monoclonal antibody-based diagnostic tests

• Molecular diagnostic methods

Takeaway

Pharmaceutical biotechnology contributes to drug discovery, therapeutic production, vaccines, diagnostics, and advanced cell- and gene-based therapies.

Key Points for Competitive Examinations

Protein Therapeutics

• Highly specific but sensitive to environmental conditions.

• Aggregation may reduce potency and increase immunogenicity.

• Correct higher-order structure is essential for biological activity.

• Glycosylation can affect stability, pharmacokinetics, biological activity, and immunogenicity.

Protein Characterization

• SDS-PAGE → Size under denaturing conditions

• SEC → Size and aggregation

• IEF → Isoelectric point (pI)

• Ion-exchange chromatography → Charge

• Mass spectrometry → Molecular mass and molecular characterization

• ELISA → Specific detection or measurement

• Western blotting → Detection of a specific protein

Monoclonal Antibodies

• Monoclonal antibody → Derived from a single B-cell clone

• Hybridoma → B lymphocyte + immortal myeloma cell

• Fab → Antigen binding

• Fc → Effector functions

• Variable region → Antigen specificity

• Monoclonal → Uniform specificity for a particular epitope

• Polyclonal → Mixture of antibodies recognizing multiple epitopes

Immunology

• Antigen → Specifically recognized

• Immunogen → Induces immune response

• Epitope → Specific antigenic determinant recognized

• Hapten → Usually requires a carrier to become immunogenic

Immobilization

• Adsorption → Simple but weaker attachment

• Covalent binding → Strong attachment; possible activity loss

• Entrapment → Physical confinement in a matrix

• Encapsulation → Enclosed by a semipermeable membrane

• Immobilized enzyme → Reusable and easier to separate

• Immobilized cells → Retained in a defined region

• Major limitation → Mass-transfer or diffusion problems

Cell Culture

• Adherent cells → Require attachment

• Suspension cells → Grow freely in liquid medium

• CHO cells → Widely used for therapeutic protein and monoclonal antibody production

• Mammalian cells are preferred when complex post-translational modifications are required.

Quick Revision: One-Minute Memory Map

PHARMACEUTICAL BIOTECHNOLOGY
↓
Protein Therapeutics → Insulin, EPO, Interferons
↓
Protein Characterization → SDS-PAGE, SEC, IEF, MS
↓
Monoclonal Antibodies → B Cell + Myeloma = Hybridoma
↓
Antigens → Antigen, Epitope, Immunogen, Hapten
↓
Enzyme Immobilization → Adsorption, Covalent, Entrapment, Encapsulation
↓
Cell Culture → CHO Cells → Recombinant Proteins & mAbs
↓
Cell Immobilization → Cells retained; mass transfer is critical
↓
Applications → Therapeutics + Vaccines + Diagnostics + Cell/Gene Therapy

Final Exam Focus

Before attempting the MCQs, make sure you can clearly distinguish:

1. Antigen vs. Immunogen

2. Antigen vs. Epitope

3. Fab vs. Fc region

4. Monoclonal vs. Polyclonal antibodies

5. SDS-PAGE vs. SEC

6. IEF vs. Ion-exchange chromatography

7. Adsorption vs. Covalent immobilization

8. Enzyme immobilization vs. Cell immobilization

9. Adherent vs. Suspension cell culture

10. Bacterial vs. Mammalian expression systems

11. Protein denaturation vs. Aggregation

12. Role of CHO cells in biopharmaceutical production

Final Takeaway

The central idea of pharmaceutical biotechnology is the use of biological systems to produce complex medicines and improve pharmaceutical processes. For competitive examinations, focus not only on definitions but also on why a particular technique, cell system, analytical method, or immobilization strategy is preferred in a given situation.

With these concepts clear, the following MCQs can be approached by applying the principles rather than relying only on memorization.

MCQ set designed for advanced pharmacy competitive examinations.

1. Pharmaceutical biotechnology is best distinguished from conventional pharmaceutical sciences by its primary use of:

A. Synthetic organic chemistry for drug discovery
B. Biological systems or organisms to develop therapeutic products
C. Physical methods for drug formulation
D. Inorganic compounds for therapeutic applications

Answer: B. Biological systems or organisms to develop therapeutic products

Explanation: Pharmaceutical biotechnology applies biotechnology principles to develop biopharmaceuticals, including recombinant proteins, monoclonal antibodies, vaccines, gene therapies, and cell-based products.

2. Which of the following is the most important reason that protein therapeutics are generally more difficult to develop and formulate than conventional small-molecule drugs?

A. Proteins have no defined molecular structure
B. Proteins are generally susceptible to structural changes and degradation
C. Proteins cannot interact with biological targets
D. Proteins are always orally bioavailable

Answer: B. Proteins are generally susceptible to structural changes and degradation

Explanation: Proteins are sensitive to temperature, pH, oxidation, aggregation, agitation, and proteolysis. Changes in higher-order structure can significantly affect biological activity and immunogenicity.

3. A therapeutic protein retains its amino acid sequence but loses its biological activity due to disruption of hydrogen bonds and disulfide interactions. Which structural level is primarily affected?

A. Primary structure only
B. Secondary structure only
C. Tertiary and/or quaternary structure
D. Genetic code

Answer: C. Tertiary and/or quaternary structure

Explanation: The primary structure is the amino acid sequence. Disruption of non-covalent interactions and disulfide bonds can alter the three-dimensional tertiary or quaternary structure, potentially resulting in loss of activity.

4. Which analytical technique is most directly useful for determining the molecular mass of a purified therapeutic protein?

A. Mass spectrometry
B. UV-visible spectroscopy alone
C. Thin-layer chromatography
D. Polarimetry

Answer: A. Mass spectrometry

Explanation: Mass spectrometry (MS) provides highly accurate molecular mass information and can also help identify post-translational modifications and sequence-related characteristics.

5. A monoclonal antibody is produced by a hybridoma formed through fusion of:

A. T lymphocyte and myeloma cell
B. B lymphocyte and myeloma cell
C. B lymphocyte and T lymphocyte
D. Stem cell and myeloma cell

Answer: B. B lymphocyte and myeloma cell

Explanation: Hybridoma technology involves fusion of an antibody-producing B lymphocyte with an immortal myeloma cell, producing a hybrid cell capable of continuous antibody production.

6. The major advantage of monoclonal antibodies over conventional polyclonal antibodies is their:

A. Ability to recognize multiple unrelated epitopes
B. Uniform specificity for a particular epitope
C. Complete absence of immunogenicity
D. Permanent stability under all storage conditions

Answer: B. Uniform specificity for a particular epitope

Explanation: Monoclonal antibodies are derived from a single B-cell clone and therefore recognize one specific epitope with high uniformity.

7. An antigen is best defined as a substance that:

A. Always produces an immune response
B. Can specifically interact with components of the immune system
C. Is always a protein
D. Can only activate T cells

Answer: B. Can specifically interact with components of the immune system

Explanation: An antigen is recognized specifically by antibodies, B-cell receptors, or T-cell receptors. Not every antigen is necessarily highly immunogenic; immunogenicity refers specifically to the ability to induce an immune response.

8. A small molecule becomes immunogenic only after covalent attachment to a larger carrier protein. The small molecule is called:

A. Adjuvant
B. Epitope
C. Hapten
D. Antibody

Answer: C. Hapten

Explanation: A hapten is a small molecule that can be recognized by the immune system but generally cannot induce an immune response independently. When linked to a carrier protein, it can become immunogenic.

9. Which analytical method is particularly useful for detecting protein aggregation based on differences in molecular size?

A. Size-exclusion chromatography
B. Ion-exchange chromatography
C. Affinity chromatography
D. Gas chromatography

Answer: A. Size-exclusion chromatography

Explanation: Size-exclusion chromatography (SEC) separates molecules according to their hydrodynamic size and is commonly used to detect protein monomers, dimers, and higher-order aggregates.

10. A therapeutic protein exhibits a slight change in its isoelectric point after manufacturing process modification. Which technique would be most appropriate for investigating this change?

A. Isoelectric focusing
B. Size-exclusion chromatography
C. SDS-PAGE only
D. Gas chromatography

Answer: A. Isoelectric focusing

Explanation: Isoelectric focusing (IEF) separates proteins according to their isoelectric point (pI) and is useful for detecting charge variants of therapeutic proteins.

11. Which technique is most appropriate for evaluating the purity and apparent molecular size of a protein under denaturing conditions?

A. SDS-PAGE
B. ELISA
C. Isoelectric focusing
D. UV spectroscopy

Answer: A. SDS-PAGE

Explanation: SDS-PAGE denatures proteins and separates them primarily according to molecular size. It is widely used to assess protein purity and detect degradation products.

12. A protein therapeutic contains an incorrect disulfide-bond arrangement but has the correct amino acid sequence. Which statement is most accurate?

A. Its primary structure is necessarily incorrect
B. Its higher-order structure may be altered
C. Its molecular weight must become zero
D. Its genetic code must have changed

Answer: B. Its higher-order structure may be altered

Explanation: Disulfide bonds contribute significantly to tertiary and quaternary protein structure. Incorrect disulfide pairing can cause misfolding and loss of biological activity.

13. Which of the following is a major concern associated with protein aggregation in pharmaceutical formulations?

A. Increased chemical purity
B. Potential increase in immunogenicity
C. Guaranteed increase in therapeutic efficacy
D. Elimination of all adverse effects

Answer: B. Potential increase in immunogenicity

Explanation: Protein aggregates can alter the immune response and may increase the risk of immunogenicity. Aggregation is therefore an important critical quality attribute of biopharmaceuticals.

14. The Fc region of an IgG monoclonal antibody is primarily responsible for:

A. Antigen-binding specificity
B. Effector functions and interaction with Fc receptors
C. Recognition of DNA sequences
D. Catalytic activity of the antibody

Answer: B. Effector functions and interaction with Fc receptors

Explanation: The Fab region primarily determines antigen-binding specificity, whereas the Fc region mediates effector functions such as interaction with Fc receptors and complement-related mechanisms.

15. Which part of an antibody directly determines its antigen-binding specificity?

A. Constant region
B. Fc region
C. Variable region
D. Hinge region only

Answer: C. Variable region

Explanation: The variable regions of the heavy and light chains, particularly their complementarity-determining regions (CDRs), form the antigen-binding site and determine specificity.

16. The principal advantage of immobilizing an enzyme in an industrial pharmaceutical process is:

A. Complete elimination of enzyme activity
B. Reuse of the enzyme and easier separation from the product
C. Conversion of the enzyme into a small molecule
D. Prevention of all enzyme denaturation

Answer: B. Reuse of the enzyme and easier separation from the product

Explanation: Immobilized enzymes can often be recovered and reused, facilitate continuous processing, and simplify product separation. Immobilization may also improve operational stability.

17. Which of the following is NOT a common method of enzyme immobilization?

A. Adsorption
B. Covalent binding
C. Entrapment
D. Complete hydrolysis of the enzyme

Answer: D. Complete hydrolysis of the enzyme

Explanation: Common immobilization approaches include adsorption, covalent attachment, cross-linking, entrapment, and encapsulation. Hydrolysis destroys the enzyme rather than immobilizing it.

18. An enzyme is trapped within the pores of a polymeric matrix but is not chemically bound to the matrix. This technique is called:

A. Covalent binding
B. Adsorption
C. Entrapment
D. Cross-linking

Answer: C. Entrapment

Explanation: In entrapment, enzyme molecules are physically confined within a matrix or gel. The enzyme is not necessarily chemically attached to the support.

19. Which immobilization method is most likely to minimize enzyme leakage from the support?

A. Simple adsorption
B. Covalent attachment
C. Passive diffusion
D. Dialysis

Answer: B. Covalent attachment

Explanation: Covalent immobilization forms strong chemical bonds between the enzyme and support, generally reducing enzyme leakage compared with simple adsorption.

20. A major disadvantage of covalent enzyme immobilization is:

A. Poor enzyme recovery
B. Possible loss of enzyme activity due to modification of critical functional groups
C. Inability to reuse the enzyme
D. Complete dissolution of the support

Answer: B. Possible loss of enzyme activity due to modification of critical functional groups

Explanation: Covalent attachment may alter the enzyme's conformation or block essential amino acid residues, potentially reducing catalytic activity.

21. Which of the following best describes the major advantage of immobilized enzymes over free enzymes in continuous pharmaceutical bioprocessing?

A. They are always more active than free enzymes
B. They can be retained within the reactor and reused
C. They cannot be affected by temperature
D. They eliminate the need for substrate

Answer: B. They can be retained within the reactor and reused

Explanation: Immobilized enzymes can remain in a bioreactor or column, allowing continuous operation and repeated use while the product is collected separately.

22. In mammalian cell culture, serum is traditionally added to the culture medium primarily because it provides:

A. Only glucose
B. Growth factors, hormones, proteins, and other nutrients
C. Only antibiotics
D. Only inorganic salts

Answer: B. Growth factors, hormones, proteins, and other nutrients

Explanation: Serum contains various growth-promoting and survival factors, hormones, attachment factors, proteins, lipids, and nutrients. However, chemically defined serum-free media are increasingly preferred for biopharmaceutical production.

23. Which cell culture system is generally most appropriate for large-scale production of recombinant monoclonal antibodies?

A. Mammalian cell culture
B. Red blood cells
C. Mature neurons
D. Platelets

Answer: A. Mammalian cell culture

Explanation: Mammalian cells, particularly Chinese hamster ovary (CHO) cells, are widely used for monoclonal antibody production because they can perform complex post-translational modifications, including appropriate glycosylation.

24. Why are CHO cells widely used for recombinant therapeutic protein production?

A. They cannot perform post-translational modifications
B. They are capable of producing complex mammalian proteins with relevant post-translational modifications
C. They produce only bacterial proteins
D. They are naturally immortal human cells

Answer: B. They are capable of producing complex mammalian proteins with relevant post-translational modifications

Explanation: CHO cells are a major expression system because they can produce complex proteins with mammalian-like folding and post-translational modifications, while also being adaptable to large-scale culture.

25. Which cell immobilization technique involves trapping viable cells within a gel matrix?

A. Entrapment
B. Lyophilization
C. Distillation
D. Dialysis

Answer: A. Entrapment

Explanation: In cell entrapment, living cells are physically confined within a porous matrix, such as alginate, while allowing nutrients and metabolites to diffuse through the matrix.

26. The major limitation of cell immobilization by entrapment is:

A. Complete inability of nutrients to enter the matrix
B. Diffusion limitations for nutrients, oxygen, and products
C. Inability to maintain viable cells
D. Immediate destruction of all cells

Answer: B. Diffusion limitations for nutrients, oxygen, and products

Explanation: Entrapped cells may experience mass-transfer limitations, especially in dense matrices, leading to reduced nutrient and oxygen availability and accumulation of metabolites.

27. A biotechnology-based manufacturing process produces a therapeutic protein that has the same amino acid sequence as the reference product but a different glycosylation pattern. The most appropriate conclusion is:

A. The products are necessarily identical in all respects
B. Glycosylation is irrelevant to therapeutic proteins
C. The difference may affect biological activity, pharmacokinetics, or immunogenicity
D. The amino acid sequence must automatically be different

Answer: C. The difference may affect biological activity, pharmacokinetics, or immunogenicity

Explanation: Post-translational modifications, especially glycosylation, can influence protein folding, stability, half-life, receptor interaction, biological activity, and immunogenicity.

28. Which combination correctly matches an analytical method with its primary application?

A. SEC — protein charge separation
B. IEF — separation based on isoelectric point
C. SDS-PAGE — separation based exclusively on pI
D. Mass spectrometry — only measurement of pH

Answer: B. IEF — separation based on isoelectric point

Explanation:

• SEC: size-based separation

• IEF: separation based on pI

• SDS-PAGE: primarily size-based separation under denaturing conditions

• MS: mass-to-charge analysis and molecular characterization

29. A therapeutic protein is exposed to elevated temperature and subsequently forms insoluble aggregates. This phenomenon is best classified as:

A. Protein denaturation and aggregation
B. DNA replication
C. Antigen presentation
D. Gene transcription

Answer: A. Protein denaturation and aggregation

Explanation: Elevated temperature can destabilize protein structure, causing unfolding or partial unfolding, followed by intermolecular association and aggregation.

30. Which statement best explains why pharmaceutical biotechnology is important for modern drug development?

A. It has completely replaced synthetic chemistry
B. It enables production of complex therapeutic molecules that are difficult or impossible to obtain by conventional synthesis
C. It is limited exclusively to antibiotics
D. It eliminates the need for quality control

Answer: B. It enables production of complex therapeutic molecules that are difficult or impossible to obtain by conventional synthesis

Explanation: Biotechnology enables the production of complex molecules such as recombinant proteins, monoclonal antibodies, vaccines, enzymes, cell therapies, and gene-based therapeutics.

31. Assertion–Reason Question

Assertion (A): Monoclonal antibodies produced by a single hybridoma clone are highly specific for a particular antigenic epitope.

Reason (R): A hybridoma originates from the fusion of one antibody-producing B cell with an immortal myeloma cell.

A. Both A and R are true, and R is the correct explanation of A
B. Both A and R are true, but R is not the correct explanation of A
C. A is true, but R is false
D. A is false, but R is true

Answer: A. Both A and R are true, and R is the correct explanation of A

Explanation: A single hybridoma clone originates from one B-cell clone, retaining its specific antibody-producing characteristics. The myeloma component provides continuous proliferation.

32. Assertion–Reason Question

Assertion (A): Immobilized enzymes are often preferred for industrial biocatalytic processes.

Reason (R): Immobilization can facilitate enzyme recovery and reuse.

A. Both A and R are true, and R is the correct explanation of A
B. Both A and R are true, but R is not the correct explanation of A
C. A is true, but R is false
D. Both A and R are false

Answer: A. Both A and R are true, and R is the correct explanation of A

Explanation: One of the key advantages of enzyme immobilization is the ability to separate the enzyme from the reaction mixture and reuse it, improving process economics.

33. Match the Following

• Column I Column II

• 1. SDS-PAGE A. Separation based on pI

• 2. Size-exclusion chromatography B. Separation based on molecular size

• 3. Isoelectric focusing C. Denaturing electrophoretic separation

• 4. Mass spectrometry D. Molecular mass determination

A. 1-C, 2-B, 3-A, 4-D
B. 1-B, 2-C, 3-D, 4-A
C. 1-A, 2-D, 3-B, 4-C
D. 1-D, 2-A, 3-C, 4-B

Answer: A. 1-C, 2-B, 3-A, 4-D

Explanation: This is a high-yield analytical characterization association:
SDS-PAGE → denaturing electrophoresis; SEC → size; IEF → pI; MS → molecular mass.

34. A recombinant therapeutic protein shows a sudden decrease in potency after storage. Analytical studies show no change in amino acid sequence but reveal extensive aggregation. Which explanation is most appropriate?

A. The primary structure is responsible for the loss of potency
B. Aggregation may alter the protein's functional three-dimensional structure
C. Aggregation necessarily increases protein activity
D. Protein aggregation has no pharmaceutical significance

Answer: B. Aggregation may alter the protein's functional three-dimensional structure

Explanation: Biological activity depends strongly on the correct higher-order structure of a protein. Aggregation may reduce the concentration of active monomer and may also increase immunogenicity.

35. Which scenario most strongly favors the use of a mammalian expression system rather than a bacterial expression system?

A. Production of a simple non-glycosylated peptide
B. Production of a complex glycoprotein requiring mammalian-like post-translational modifications
C. Production of glucose
D. Production of sodium chloride

Answer: B. Production of a complex glycoprotein requiring mammalian-like post-translational modifications

Explanation: Mammalian expression systems are preferred for proteins requiring complex folding, glycosylation, disulfide bond formation, and other post-translational modifications that may not be accurately reproduced in bacterial systems.

Rapid Revision: Most Important Exam Traps

• Antigen ≠ immunogen: An antigen can be recognized by the immune system; an immunogen can induce an immune response.

• Hapten: Usually immunogenic only after attachment to a suitable carrier.

• Fab region: Mainly responsible for antigen recognition and binding.

• Fc region: Responsible for many antibody effector functions.

• Monoclonal antibody: Derived from a single B-cell clone and recognizes a specific epitope.

• Hybridoma: B lymphocyte + immortal myeloma cell.

• SDS-PAGE: Primarily separates proteins by molecular size under denaturing conditions.

• SEC: Separates proteins according to size/hydrodynamic volume.

• IEF: Separates proteins according to isoelectric point.

• Mass spectrometry: Important for molecular mass and detailed protein characterization.

• Enzyme immobilization: Allows recovery and reuse; may improve operational stability.

• Entrapment: Physical confinement of enzymes or cells within a matrix.

• Covalent immobilization: Strong attachment but may reduce activity if critical residues are affected.

• CHO cells: Widely used for production of recombinant therapeutic proteins and monoclonal antibodies.

• Protein aggregation: Can reduce potency and increase immunogenicity.

• Glycosylation: Can affect stability, pharmacokinetics, biological activity, and immunogenicity.

• Protein therapeutics: Highly sensitive to temperature, pH, oxidation, agitation, proteolysis, and formulation conditions.

Dr Alok Singh